Clinical Trial

Improving Breast Cancer Screening Uptake Through Tailored Reminder Letters

Study acronym: ENTER
Completed
View on ClinicalTrials.gov →
Summary
The goal of this trial is to learn whether a culturally and linguistically tailored reminder letter can increase participation in the Flemish Breast Cancer Screening Program among women who previously did not attend screening. The study also examines whether the effect differs between socioeconomic groups. The main questions it aims to answer are: * Does a tailored reminder letter increase participation among previous non-attenders? * Does the effect differ between women with lower and higher socioeconomic status? Researchers compare two groups: * Intervention group: receive the standard invitation letter plus an additional tailored reminder letter. * Control group: receive the standard invitation letter only. Participation in screening within 40 days of the invitation is measured using the program's registry. Participants are women aged 50-69 years who had previously been invited but had never attended screening. The reminder letter is sent as part of routine screening communication, and no additional medical procedures are involved.
Trial Details
NCT Number NCT07472036
Lead Sponsor Universiteit Antwerpen
Collaborators: Thomas More University of Applied Sciences, Centre for Cancer Detection (CvKO), Intermutualistic Agency, Stichting tegen Kanker
Conditions Health Behavior, Breast Cancer Screening, Mammography
Enrollment 7,947 participants
Start Date 2024-04-01
Primary Completion 2024-09-30 (estimated)
Study Completion 2025-12-16 (estimated)
Updated on ClinicalTrials.gov 2026-03-16